ME3 and neoplasm: The efficacy of TMZ was limited in GBM-24 tumors with higher Me3-NFAT5 K668 expression levels, whereas TMZ combined with DZNep inhibited tumor growth and prolonged the survival time of mice (Fig. 8f–i).